Androgen Receptor Antagonists in the Treatment of Prostate Cancer

ISSN： 2212-7070

Source： Clinical Immunology, Endocrine & Metabolic Drugs, Vol.1, Iss.1, 2014-06, pp. : 11-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Androgen Receptor Antagonists in Prostate Cancer

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 8, 2014-06 ,pp. : 655-663

Bentham Science Publishers

Access to resources Recommend Favorite

New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 290-302

Bentham Science Publishers

Access to resources Recommend Favorite

The androgen receptor as a therapeutic target in prostate cancer

By Visakorpi T.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

New Features in the Treatment of Androgen-Independent Prostate Cancer

Current Pharmaceutical Design, Vol. 10, Iss. 5, 2004-02 ,pp. : 513-522

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 420-440

Bentham Science Publishers

Access to resources Recommend Favorite